Editor’s Choice: Lunchbox Trial
Listen now
Description
Editor’s Choice Paper:
Lunchbox trial: A randomized phase III trial of cisplatin and irradiation followed by carboplatin and paclitaxel versus sandwich therapy of carboplatin and paclitaxel followed by irradiation then carboplatin and paclitaxel for advanced endometrial carcinoma
Editorial:
What's in your “lunchbox”? Sandwich versus sequential chemotherapy and irradiation for advanced endometrial cancer
Hosted by:
Ursula Matulonis, MD, Associate Editor of Gynecologic Oncology
Featuring:
Joyce Barlin, MD, Women’s Cancer Care Associates & Albany Medical College
Gretchen Glaser, MD, Mayo Clinic
John Weroha, MD, Mayo Clinic
More Episodes
Editor’s Choice Paper:
Identifying safe diagnostic algorithms for sentinel lymph node mapping in high-risk endometrial cancer: The SENTIREC-endo study
Editorial:
Sentinel lymph node biopsy in high-risk endometrial cancer: The dénouement
Hosted by:
Gregg Nelson, MD, Social Media Editor...
Published 04/15/24
Published 04/15/24
Editor’s Choice Paper:
Experiences of patients with peritoneal carcinomatosis-related complex care needs and their caregivers
Editorial:
The importance of family-focused care in the setting of advanced gynecological cancers
Hosted by:
Sean Dowdy, MD, Associate Editor of Gynecologic...
Published 04/04/24
Links
Twitter
Facebook
Instagram
Patreon
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »
See hourly chart positions and more than 30 days of history.
